Yvonne Greenstreet
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Yvonne Greenstreet
Yvonne Greenstreet is recorded as COO and CEO at Alnylam Pharmaceuticals, Inc. (ALNY). The proxy statement of Alnylam Pharmaceuticals, Inc. reports total compensation of $14,867,600 for Yvonne Greenstreet in fiscal 2025, including a base salary of $1,404,200. Disclosed compensation is on record for 9 fiscal years. Yvonne Greenstreet has spoken on 26 earnings calls and 1 other investor event across 1 company, most recently for Alnylam Pharmaceuticals, Inc. on September 14, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Alnylam Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Yvonne L. Greenstreet CEO, COO, Board Member
- Amy W. Schulman Chairman, Board Member
- Michael Bonney Chairman
- Michael W. Bonney Chairman
- Jeffrey Poulton CFO
- Manmeet S CFO
- Akshay K. Vaishnaw, M.D., Ph.D. CIO
- Benjamin F. Cravatt Board Member
- Benjamin F. Cravatt, Ph.D. Board Member
- Carolyn R. Bertozzi Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $1,404,200 | $14,867,600 |
| 2024 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $1,253,400 | $11,492,970 |
| 2023 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $975,800 | $8,895,670 |
| 2022 | Alnylam Pharmaceuticals, Inc. (ALNY) | Chief Executive Officer (principal executive officer) | $850,000 | $4,588,810 |
| 2021 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA Chief Executive Officer (principal executive officer) | $619,100 | $8,575,220 |
| 2020 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA Chief Executive Officer (principal executive officer) | $621,500 | $3,034,001 |
| 2019 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA President and Chief OperatingOfficer | $571,423 | $3,250,025 |
| 2018 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA President and Chief OperatingOfficer | $540,000 | $2,682,755 |
| 2017 | Alnylam Pharmaceuticals, Inc. (ALNY) | MBChB, MBA ChiefOperating Officer | $504,200 | $984,674 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.